[Fund Index | Funds By Family | Fund Top Performers]

Mutual Fund Top Performers - Muni Single State Short

As of 30-Jun-09

Select a symbol for a detailed quote and links to additional information.

Top Performers - 3 Month (out of 14) Fund Name Symbol Return Montana Tax-Free A MTTAX 2.94% Montana Tax-Free B MTTFX 2.82% New Hampshire Municipal NHMUX 1.59% PNC MD Tax-Exempt Bond I PDTIX 1.11% PNC MD Tax-Exempt Bond A PDTAX 0.98% Alabama Tax-Free Bond ALABX 0.85% PNC MD Tax-Exempt Bond C PDTCX 0.77% Brown Advisory MD Bond BIAMX 0.69% T. Rowe Price MD Short-Term Tax-Free PRMDX 0.60% Dupree NC Tax-Free Short-to-Medium NTSMX 0.45%
Top Performers - 1 Year (out of 14) Fund Name Symbol Return PNC MD Tax-Exempt Bond I PDTIX 5.54% Dupree TN Tax-Free Short-to-Medium TTSMX 5.31% Brown Advisory MD Bond BIAMX 5.19% PNC MD Tax-Exempt Bond A PDTAX 5.11% Dupree NC Tax-Free Short-to-Medium NTSMX 5.04% Dupree KY Tax-Free Short-to-Medium KYSMX 5.01% Alabama Tax-Free Bond ALABX 4.80% PNC MD Tax-Exempt Bond C PDTCX 4.09% T. Rowe Price MD Short-Term Tax-Free PRMDX 4.06% New Hampshire Municipal NHMUX 3.83%		Top Performers - 3 Year (out of 14) Fund Name Symbol Ann. Ret. PNC MD Tax-Exempt Bond I PDTIX 4.37% Brown Advisory MD Bond BIAMX 4.25% Alabama Tax-Free Bond ALABX 4.14% Dupree KY Tax-Free Short-to-Medium KYSMX 4.02% T. Rowe Price MD Short-Term Tax-Free PRMDX 3.95% Dupree NC Tax-Free Short-to-Medium NTSMX 3.92% PNC MD Tax-Exempt Bond A PDTAX 3.85% Dupree TN Tax-Free Short-to-Medium TTSMX 3.84% New Hampshire Municipal NHMUX 3.54% PNC MD Tax-Exempt Bond C PDTCX 3.17%
Top Performers - 5 Year (out of 14) Fund Name Symbol Ann. Ret. PNC MD Tax-Exempt Bond I PDTIX 3.44% Brown Advisory MD Bond BIAMX 3.29% Alabama Tax-Free Bond ALABX 3.24% Dupree KY Tax-Free Short-to-Medium KYSMX 3.07% Dupree NC Tax-Free Short-to-Medium NTSMX 2.98% T. Rowe Price MD Short-Term Tax-Free PRMDX 2.96% PNC MD Tax-Exempt Bond A PDTAX 2.93% Dupree TN Tax-Free Short-to-Medium TTSMX 2.89% New Hampshire Municipal NHMUX 2.51% Montana Tax-Free A MTTAX 2.34%

Get Morningstar's portfolio tools, data, and editorial insights, plus Analyst Reports on 1,450 stocks and 2,000 funds. Start your free 14-day trial today.